| Name | Title | Contact Details |
|---|
Xena Health is a Hartford, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CCISCO: Contra Costa Interfaith is a Martinez, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Our mission—empowering our customers to achieve their best health—exemplifies our commitment to look at healthcare differently. But even more importantly, we look at you, the customer, differently. We believe that healthcare can be better and this is what really drives us. At North Memorial Health, you have a voice and we listen. You have health goals and we have the knowledge and the tools to help you get there. Even when illness or injury steals your strength, we will not let it steal your power. We believe when you`re engaged and informed, you will have better health and a better life.
AudioNet is a National Provider Network that sub-contracts with various Hearing Aid networks throughout the country to give eligible members the best selection of product and service under one network administrator. We have successfully sub-contracted with over 5,000 Audiologists/ENTs nationally to meet the contractual requirements of our customers, as well as the members needs. Mandating only the most qualified providers to service our members and monitoring the quality of products rendered, AudioNet is able to bring a level of Provider Accountability to the Hearing Aid industry that has never before been seen. Negotiating for State of the Art digital products within a National Provider Network allows the eligible member a tremendous benefit enhancement of upto Two (2) Standard Digital Hearing Aids, covered in full. The Fee Schedules, Product Models and Styles, etc., approved for distribution In-Network are outlined on this website.
MRI Interventions, Inc. is a medical device company that develops and commercializes innovative platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging, or MRI, guidance. Since our inception in 1998, we have focused on research and product development in the field of interventional MRI. From 1998 to 2002, we deployed significant resources to fund our efforts to develop the foundational capabilities for enabling MRI-guided interventions and to build an intellectual property position. In 2003, our focus shifted to identifying and building out commercial applications for the technologies we developed in prior years. We have two product platforms. Our ClearPoint® system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. Our ClearTrace system, which is still in development, will be used to perform minimally invasive surgical procedures in the heart. Both systems utilize intra-procedural magnetic resonance imaging to guide the procedures. Both systems are designed to work in a hospital’s existing MRI suite. Our products are designed to provide a new, minimally invasive surgical approach for the benefit of large patient populations. Our ClearPoint system is designed to enable the delivery of therapies to treat certain neurological diseases. Our ClearTrace system is designed to deliver therapies to treat certain cardiac diseases. We believe that our two product platforms, subject to appropriate regulatory clearance and approval, will provide better patient outcomes, enable physicians and hospitals to treat more patients, and reduce costs to the healthcare system.